Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fátima González Testón"'
Autor:
Sergio Gamaza-Chulián, Fátima González-Testón, Enrique Díaz-Retamino, Francisco M. Zafra-Cobo, Eva González-Caballero
Publikováno v:
Cardiovascular Ultrasound, Vol 21, Iss 1, Pp 1-9 (2023)
Abstract Background Although indexing effective orifice area (EOA) by body surface area (BSA) is recommended, this method has several disadvantages, since it corrects by acquired fatty tissue. Our aim was to analyze the value of EOA normalized by hei
Externí odkaz:
https://doaj.org/article/681bada1e2de4e06a451b34adf701ba2
Autor:
Sergio Gamaza-Chulián, Enrique Díaz-Retamino, Fátima González-Testón, José Carlos Gaitero, María José Castillo, Raquel Alfaro, Elías Rodríguez, Eva González-Caballero, Antonio Martín-Santana
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Sodium-glucose cotransporter 2 inhibitors (SGLT2i) lower cardiovascular events in type 2 diabetes mellitus (T2DM) patients, although the mechanisms underlying these benefits are not clearly understood. Our aim was to study the eff
Externí odkaz:
https://doaj.org/article/e3c37f04a1244b5bb227d6a7d2a1f006
Autor:
Fátima González Testón, Sergio Gamaza Chulian, Enrique Diaz Retamino, José Carlos Gaitero Reina, Antonio Martín Santana, Eva González Caballero
Publikováno v:
REC: CardioClinics. 58:S1
Autor:
Raquel Alfaro, Eva González-Caballero, Antonio Martín-Santana, Fátima González-Testón, José Carlos Gaitero, Elías Rodríguez, Sergio Gamaza-Chulián, Enrique Díaz-Retamino, María José Castillo
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cardiovasc Disord 21, 456 (2021)
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
instname
BMC Cardiovascular Disorders
BMC Cardiovasc Disord 21, 456 (2021)
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
instname
BMC Cardiovascular Disorders
Background Sodium-glucose cotransporter 2 inhibitors (SGLT2i) lower cardiovascular events in type 2 diabetes mellitus (T2DM) patients, although the mechanisms underlying these benefits are not clearly understood. Our aim was to study the effects of S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9c0f06f738407ab1ac6868b00db15c5
https://doi.org/10.21203/rs.3.rs-582026/v2
https://doi.org/10.21203/rs.3.rs-582026/v2